Anti-CD19 & CD3 Reference Antibody (Blinatumomab)

Artikelnummer: SYB-CHBA068
Artikelname: Anti-CD19 & CD3 Reference Antibody (Blinatumomab)
Artikelnummer: SYB-CHBA068
Hersteller Artikelnummer: CHBA068
Alternativnummer: SYB-CHBA068-100UG, SYB-CHBA068-1MG
Hersteller: Sanyou Bio
Kategorie: Antikörper
Applikation: ELISA, FA, FACS, Kinetics
Lulizumab is a monovalent Anti-Human CD28 Domain Antibody Antagonist designed for the treatment of autoimmune diseases.
Konzentration: 1mg/ml
UniProt: P15391
Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Reinheit: >95%
Formulierung: Lyophilize
Target-Kategorie: CD19,CD3